Showing results (111-120 of 123) with videos related to
Sort By:
Pageof 13
The New England Journal of Medicine|May 11, 2022
Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of AgeC Buddy Creech, Evan Anderson, Vladimir Berthaud, et al.Journal of Medicinal Chemistry|June 4, 2011
Discovery of (2E)-3-{2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an orally active histone deacetylase inhibitor with a superior preclinical profileHaishan Wang, Niefang Yu, Dizhong Chen, et al.Gastroenterology|August 9, 2013
Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trialFred Poordad, Eric Lawitz, K Rajender Reddy, et al.Hepatology (Baltimore, Md.)|May 22, 2012
Rare inborn errors associated with chronic hepatitis B virus infectionQiang Zhao, Liang Peng, Weijun Huang, et al.The New England Journal of Medicine|December 30, 2020
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineLindsey R Baden, Hana M El Sahly, Brandon Essink, et al.The Lancet. Infectious Diseases|June 22, 2023
Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trialIvan T Lee, Catherine A Cosgrove, Patrick Moore, et al.The New England Journal of Medicine|September 22, 2021
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded PhaseHana M El Sahly, Lindsey R Baden, Brandon Essink, et al.The New England Journal of Medicine|October 19, 2022
Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of AgeEvan J Anderson, C Buddy Creech, Vladimir Berthaud, et al.Science (New York, N.Y.)|November 23, 2021
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trialPeter B Gilbert, David C Montefiori, Adrian B McDermott, et al.Medrxiv : the Preprint Server for Health Sciences|August 17, 2021
Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy TrialPeter B Gilbert, David C Montefiori, Adrian McDermott, et al.Pageof 13